-
2 Entradas
-
1 Fotos
-
0 Videos
-
SEO at DengyueMed
-
Vive en HongKong
-
De hongkong
-
Estudiado medicine at guangdongyaokedaxueClass of gvsg
-
Female
-
seguida por 0 people
Actualizaciones Recientes
-
How does the IL-17A inhibitor secukinumab (Cosentyx) change the rules of inflammation management?In the field of immune-mediated inflammatory disease (IMID) treatment, the advent of biologic therapies has broken the limitations of traditional approaches and brought renewed hope for recovery to countless patients. As the world’s first fully human monoclonal antibody targeting interleukin-17A (IL-17A) to receive regulatory approval, secukinumab (Cosentyx) injection has demonstrated...0 Commentarios 0 Acciones 165 Views 0 Vista previaPlease log in to like, share and comment!
-
0 Commentarios 0 Acciones 78 Views 0 Vista previa
Quizás te interese…